ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy
- 11 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neuroimmune Pharmacology
- Vol. 16 (1), 59-70
- https://doi.org/10.1007/s11481-020-09979-8
Abstract
COVID-19 is an infectious respiratory illness caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and until now, there is no effective therapy against COVID-19. Since SARS-CoV-2 binds to angiotensin-converting enzyme 2 (ACE2) for entering into host cells, to target COVID-19 from therapeutic angle, we engineered a hexapeptide corresponding to the ACE2-interacting domain of SARS-CoV-2 (AIDS) that inhibits the association between receptor-binding domain-containing spike S1 and ACE-2. Accordingly, wild type (wt), but not mutated (m), AIDS peptide inhibited SARS-CoV-2 spike S1-induced activation of NF-κB and expression of IL-6 in human lungs cells. Interestingly, intranasal intoxication of C57/BL6 mice with recombinant SARS-CoV-2 spike S1 led to fever, increase in IL-6 in lungs, infiltration of neutrophils into the lungs, arrhythmias, and impairment in locomotor activities, mimicking some of the important symptoms of COVID-19. However, intranasal treatment with wtAIDS, but not mAIDS, peptide reduced fever, protected lungs, improved heart function, and enhanced locomotor activities in SARS-CoV-2 spike S1-intoxicated mice. Therefore, selective targeting of ACE2-to-SARS-CoV-2 interaction by wtAIDS may be beneficial for COVID-19. Graphical AbstractKeywords
Funding Information
- National Institutes of Health (AG050431)
- National Institutes of Health (AT010980)
- National Institutes of Health (NS108025)
- U.S. Department of Veterans Affairs (1IK6 BX004982)
This publication has 32 references indexed in Scilit:
- The co-pathogenesis of influenza viruses with bacteria in the lungNature Reviews Microbiology, 2014
- Regulation of Cyclic AMP Response Element Binding and Hippocampal Plasticity-Related Genes by Peroxisome Proliferator-Activated Receptor αCell Reports, 2013
- The microbiology of asthmaNature Reviews Microbiology, 2012
- An Official American Thoracic Society Workshop Report: Features and Measurements of Experimental Acute Lung Injury in AnimalsAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- Multiple Facets of NF-κB in the HeartCirculation Research, 2011
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's diseaseProceedings of the National Academy of Sciences of the United States of America, 2007
- Drugs targeting the renin–angiotensin–aldosterone systemNature Reviews Drug Discovery, 2002
- Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related CarboxypeptidaseOnline Journal of Public Health Informatics, 2002
- Induction of Nitric-oxide Synthase and Activation of NF-κB by Interleukin-12 p40 in Microglial CellsOnline Journal of Public Health Informatics, 2001